Empagliflozin in acute myocardial infarction: the EMMY trial.

Dirk von Lewinski, Ewald Kolesnik, Norbert J Tripolt, Peter N Pferschy, Martin Benedikt, Markus Wallner, Hannes Alber, Rudolf Berger, Michael Lichtenauer (Co-author), Christoph H Saely, Deddo Moertl, Pia Auersperg, Christian Reiter, Thomas Rieder, Jolanta M Siller-Matula, Gloria M Gager, Matthias Hasun, Franz Weidinger, Thomas R Pieber, Peter M ZechnerMarkus Herrmann, Andreas Zirlik, Rury R Holman, Abderrahim Oulhaj, Harald Sourij

Research output: Contribution to journalOriginal Articlepeer-review

164 Citations (Web of Science)
Original languageEnglish
Pages (from-to)4421-4432
JournalEUROPEAN HEART JOURNAL
Volume43
Issue number41
DOIs
Publication statusPublished - 2022

Keywords

  • NATRIURETIC PEPTIDE
  • EJECTION FRACTION
  • HEART-FAILURE
  • NEPRILYSIN INHIBITION
  • CLINICAL-OUTCOMES
  • SGLT2 INHIBITORS
  • PROGNOSTIC VALUE
  • FOLLOW-UP
  • ASSOCIATION
  • RECOVERY

Cite this